All the news Showing 10 of 153 articles from: United StatesGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Coronavirus US CDC recommends third dose of Moderna or Pfizer COVID-19 vaccines for organ transplant recipients Keith Alcorn / 16 August 2021 People who have undergone a solid organ transplant and who received the Pfizer or Moderna COVID-19 vaccines should receive a third dose, the US Centers for Disease Control and Prevention (CDC) recommended ... NAFLD Food insecurity raises the risk of death in people with fatty liver disease Keith Alcorn / 28 June 2021 Food insecurity – limited or unreliable food supplies due to poverty – was associated with an increased risk of death in US adults with non-alcoholic fatty liver disease (NAFLD) or advanced fibrosis ... Liver transplants Liver transplant outcomes improve in people with HIV and hepatitis C Keith Alcorn / 21 June 2021 Survival after a liver transplant has improved significantly in people with HIV and hepatitis C co-infection since the introduction of direct-acting antiviral treatment for hepatitis C, US researchers report in the journal Transplantation ... Screening and testing policy COVID-19 reduced US hepatitis C testing, diagnosis and treatment Keith Alcorn / 21 May 2021 The COVID-19 pandemic severely reduced hepatitis C testing, diagnosis and treatment in the United States during 2020, a study by Quest Diagnostics and the US Centers for Disease Control and Prevention (CDC) ... Screening and testing policy Hepatitis C testing in gay and bisexual men with HIV below target, US study finds Keith Alcorn / 27 April 2021 Testing for hepatitis C among gay and bisexual men with HIV who are at higher risk of acquiring hepatitis C is falling short of recommendations, a study of a large US cohort ... Hepatitis C elimination Community-wide hepatitis C elimination campaign in Seattle increases number treated tenfold Keith Alcorn / 20 April 2021 A community-wide hepatitis C elimination campaign in Seattle, United States, tripled the number of people screened for hepatitis C and increased the number treated tenfold between 2014 and 2018, doctors and public health ... Sexual transmission Reinfection after hepatitis C cure predicted by sexually transmitted infections Keith Alcorn / 07 April 2021 Screening for sexually transmitted infections in people co-infected with HIV and hepatitis C during or shortly after completing direct-acting antiviral treatment to cure hepatitis C may predict which patients are at higher risk ... Hepatitis C elimination 12 good practices that should be part of the hepatitis C standard of care Keith Alcorn / 25 March 2021 Hepatitis C programmes and health services should review whether they are using best practices in diagnosis, treatment and care of people with hepatitis C, and update service models to improve hepatitis C elimination ... Coronavirus Hepatitis C does not raise the risk of death from COVID-19 Keith Alcorn / 19 February 2021 People with hepatitis C were more likely to be admitted to hospital as a result of SARS-CoV-2 infection but no more likely to die when compared to people without hepatitis C of ... Adherence to treatment High adherence and hepatitis C cure rates in active drug and alcohol users Keith Alcorn / 04 February 2021 People who use drugs achieved high rates of hepatitis C cure on direct-acting antiviral treatment despite ongoing drug and alcohol use, demonstrating that active drug use should not be a barrier to ... ← Prev12345...16Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Noticeboard Email bulletins News feeds